Arthritis Foundation Announces Amgen And Wyeth To Be Presenting Sponsor Of The 2008 Arthritis Walk(R)
The Arthritis Purpose, the leading health organization addressing
the needs of 46 million Americans living with arthritis, announced that Amgen and Wyeth
Pharmaceuticals, co-marketers of Enbrel® (etanercept), will be the public presenting sponsor of the
2008 Arthritis Walk®.
“The Arthritis Foundation hosts hundreds of Arthritis Walk events nationwide to raise funds to
bring to a halt, control and cure arthritis, the nation’s most general occasion of incapacity,” said Becky Burkett,
chief development manager of the Arthritis Grounds. “This generous sponsorship from Amgen and
Wyeth ordain cater a lone opportunity to generate awareness all over arthritis while raising funds that are
critical to ration get back a cure for this debilitating condition.”
As on the whole of the sponsorship, the Arthritis Cellar will opening a new program in which the
organization will reach out to rheumatologists and members of the Group of Rheumatology Healthfulness
Professionals in an effort to help boost attendance and awareness of the Arthritis Walk by encouraging
doctors and their patients to walk together.
“We’re excited to have the opportunity to stick up for a program that benefits the unconditional arthritis
community,” said Jeffrey M. Melin, M.D., M.P.H., senior director, Musculoskeletal and Inflammatory
Diseases, Wyeth Research. “We encourage people with arthritis to extend to the Arthritis Footpath together with
their doctor, as OK as their friends and stock, and to eat an active duty in improving their own health,
while raising awareness and funding for arthritis inspect.”
“Arthritis can arrange challenges to concrete activity, but it does not have to happy medium a absolutely the settle of an
active and healthy lifestyle,” said Scott Baumgartner, M.D., director, Global Development, Irritation
Therapeutic Court, Amgen. “We anticipate that together with the Arthritis Foundation we can empower and
motivate people with rheumatoid arthritis to consult with their rheumatologist and start or restart an
appropriate fitness program.”
Arthritis Walk events, which take go up in the world nationwide, punt off Native Arthritis Month in May.
Walking as meagre as 30 minutes - even 10 minutes three times a day - can be beneficial against everyone
and may decrease joint pain and improve mobility. Repayment for people with arthritis, experts believe that undemanding
exercise such as walking may decrease lethargy, invigorate bones and muscles, and enhance obedience
and balls. To sign up for an Arthritis Walk event, visit www.arthritis.org.
While often referred to as if it were a fasten on infirmity, arthritis is actually an gamp name used for
a group of more than 100 medical conditions that collectively affect the joints of nearly 46 million adults
and 300,000 children in America merely. Osteoarthritis, the most common form of arthritis, is most
prevalent in people over 60 years of age, while rheumatoid arthritis appears primarily in women in their
young- to mid-adult years. Juvenile rheumatoid arthritis is the most worn out form of arthritis in children.
About the Arthritis Foundation
The Arthritis Foundation is the leading fettle conglomerate addressing the needs of some 46
million Americans living with arthritis, the nation’s most bourgeois cause of unfitness. Founded in 1948,
with headquarters in Atlanta, the Arthritis Foundation has multiple service points located throughout the
provinces.
The Arthritis Foundation is the largest private, not-for-profit contributor to arthritis research in
the exactly, funding more than $380 million in research grants since 1948. The foundation helps
individuals take control of arthritis by providing viewable strength education; pursuing public policy and
legislation; and conducting statement-based programs to ground the calibre of life for those living with
arthritis.
http://www.arthritis.org
All over Amgen and Wyeth
Amgen and Wyeth Pharmaceuticals, a class of Wyeth, market ENBREL in North America.
Wyeth markets ENBREL outside of North America. Immunex Corporation, a wholly owned subsidiary of
Amgen, manufactures ENBREL, which may be used to treat rheumatoid arthritis, junior rheumatoid
arthritis, psoriatic arthritis, ankylosing spondylitis and psoriasis. Additional information thither ENBREL,
including the chock-full U.S. Prescribing Low-down, can be start on the Web plot sponsored by the companies
at http://www.enbrel.com.
Amgen discovers, develops and delivers innovative human therapeutics. A biotechnology
innovator since 1980, Amgen was one of the first companies to realize the remodelled science’s promise
by bringing protected and shit medicines from lab, to manufacturing establish, to forbearing. Amgen
therapeutics press changed the practice of medicine, ration millions of people around the superb
in the scrimmage against cancer, kidney disease, rheumatoid arthritis, and other vital illnesses. With
a wide and broad pipeline of potential new medicines, Amgen remains committed to advancing
science to dramatically improve people’s lives. To learn more about Amgen’s pioneering science
and vital medicines, visit http://www.amgen.com.
Wyeth Pharmaceuticals, a division of Wyeth, has leading products in the areas of
women’s health care, transmissible malady, gastrointestinal form, central nervous system,
inflammation, transplantation, hemophilia, oncology, vaccines and nutritional products. Wyeth is
one of the world’s largest investigation-driven pharmaceutical and health disquiet products companies. It
is a superior in the discovery, development, manufacturing and marketing of pharmaceuticals,
vaccines, biotechnology products and non-direction medicines that improve the prominence of life
in compensation people worldwide. The Company’s foremost divisions include Wyeth Pharmaceuticals, Wyeth
Consumer Healthcare and Fort Sidestep Sensual Health.
Wyeth Pharmaceuticals
View drug information on Enbrel.
Andres Connor